《科学美国人》 第334卷 第1期 · 2026年1月刊 · 中文解读
亨廷顿病的希望:新疗法减缓疾病进展
Advances: Huntington's Hopes
约 9 分钟Advances在小程序里点播,20 到 60 分钟做好
这篇讲什么
一项实验性基因疗法药物AMT-130在临床试验中首次显示出减缓亨廷顿病进展的效果,为患者带来希望。
原文开头
Huntington’s Hopes After years of heartbreak, a new treatment slows this devastating disease EVERY WEEK neurologist Victor Sung sees people with Huntington’s disease, a rare and deadly neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But a Wednesday last September was a day unlike any other. “I cried with every single patient,” Sung says. The results of crucial phase 1/2 clinical trials had finally been released: an experimental gene therapy drug was the first treat- ment that appeared to slow the progres- sion of Huntington’s. When someone is diagnosed with Huntington’s, their treatment options are limited. …
摘自《科学美国人》(Scientific American)第334卷 第1期 · 2026年1月刊。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。

微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号